Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,952 | 2 | 91.1% |
| Food and Beverage | $289.50 | 6 | 8.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $2,952 | 2 | $0 (2018) |
| ITI, Inc. | $119.51 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $104.16 | 1 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $65.83 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $119.51 | 1 | ITI, Inc. ($119.51) |
| 2019 | $147.73 | 4 | Janssen Pharmaceuticals, Inc ($104.16) |
| 2018 | $2,952 | 2 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($2,952) |
| 2017 | $22.26 | 1 | ACADIA Pharmaceuticals Inc ($22.26) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $119.51 | General |
| Category: PSYCHIATRY | ||||||
| 06/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $104.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/04/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/04/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/07/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/28/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | BREXPIPRAZOLE (Drug) | Consulting Fee | Cash or cash equivalent | $1,968.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | BREXPIPRAZOLE (Drug) | Consulting Fee | Cash or cash equivalent | $984.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/01/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: PDP | ||||||
About Dr. Ashok Patel, MD
Dr. Ashok Patel, MD is a Psychiatry healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497821342.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashok Patel, MD has received a total of $3,242 in payments from pharmaceutical and medical device companies, with $119.51 received in 2023. These payments were reported across 8 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($2,952).
Practice Information
- Specialty Psychiatry
- Location Bronx, NY
- Active Since 11/24/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497821342
Products in Payments
- BREXPIPRAZOLE (Drug) $2,952
- CAPLYTA (Drug) $119.51
- XARELTO (Drug) $104.16
- NUPLAZID (Drug) $65.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Bronx
George Kruse, M.d, M.D
Psychiatry — Payments: $1.2M
Dr. James Chou, M.d, M.D
Psychiatry — Payments: $283,906
Marianne Goodman, M.d, M.D
Psychiatry — Payments: $45,158
Michael Hargrove, M.d, M.D
Psychiatry — Payments: $24,363
Charles Jin, Md, MD
Psychiatry — Payments: $11,981
Miss. Virginia Contreras, Md, MD
Psychiatry — Payments: $11,004